All posts from Zacks
Zacks in Our Research. Your Success.,

Company News for July 12, 2017

•    Shares of Amicus Therapeutics, Inc. FOLD soared 25.9% following news that the company has received permission from the U.S. Food and Drug Administration to submit an experimental drug for approval

•    Simulations Plus, Inc.’s SLP shares gained 6.2% after posting fiscal third-quarter revenues of $6.75 million, outpacing the Zacks Consensus Estimate of $6 million

•    Shares of Arena Pharmaceuticals, Inc. ARNA surged 41.4% following positive mid-stage trial results for its drug ralinepag

•    Evogene Ltd’s EVGN shares surged 10.8% after the company declared that it has reached an important stage in crop disease collaboration with Monsanto Company MON

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Simulations Plus, Inc. (SLP): Free Stock Analysis Report
Arena Pharmaceuticals, Inc. (ARNA): Free Stock Analysis Report
Amicus Therapeutics, Inc. (FOLD): Free Stock Analysis Report
Monsanto Company (MON): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research